
ASLAN Pharmaceuticals Limited ASLN
Geschäftsbericht 2020
hinzugefügt 19.08.2023
ASLAN Pharmaceuticals Limited EV 2011-2026 | ASLN
EV Jährlich ASLAN Pharmaceuticals Limited
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| - | 97.3 M | 66.7 M | 95.5 M | -34.8 M | -39.6 M | 63.1 M | 31.2 M | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 97.3 M | -39.6 M | 39.9 M |
EV anderer Aktien in der Pharmaeinzelhändler
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
1.82 B | - | 2.43 % | $ 254 M | ||
|
Aligos Therapeutics
ALGS
|
82.6 M | $ 8.71 | 0.81 % | $ 86.1 M | ||
|
Allakos
ALLK
|
122 M | - | - | $ 28.6 M | ||
|
Alterity Therapeutics Limited
ATHE
|
-28.9 M | $ 3.6 | -1.64 % | $ 8.66 B | ||
|
Aptinyx
APTX
|
-18.3 M | - | -39.0 % | $ 4.57 M | ||
|
Aravive
ARAV
|
58.2 M | - | -13.39 % | $ 1.45 M | ||
|
I-Mab
IMAB
|
8.28 B | - | - | $ 866 M | ||
|
AlloVir
ALVR
|
-55.1 M | - | 4.14 % | $ 49.1 M | ||
|
Applied Molecular Transport
AMTI
|
7.6 M | - | - | $ 10.1 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
1.95 B | - | - | $ 40.3 B | ||
|
BioNTech SE
BNTX
|
-4.91 B | $ 99.4 | 2.79 % | $ 27.2 B | ||
|
Genfit SA
GNFT
|
168 B | - | 2.54 % | $ 160 B | ||
|
Biophytis SA
BPTS
|
525 M | - | -13.47 % | $ 169 M | ||
|
Brainstorm Cell Therapeutics
BCLI
|
11 M | - | -2.5 % | $ 5.88 M | ||
|
Applied Therapeutics
APLT
|
563 M | - | - | $ 8.42 M | ||
|
Burford Capital Limited
BUR
|
3.22 B | $ 4.72 | 5.23 % | $ 756 M | ||
|
Cabaletta Bio
CABA
|
253 M | $ 3.24 | 1.09 % | $ 326 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
3.41 B | - | -1.52 % | $ 24.7 M | ||
|
BeiGene, Ltd.
BGNE
|
-720 M | - | 0.49 % | $ 251 B | ||
|
bluebird bio
BLUE
|
270 M | - | - | $ 546 M | ||
|
Midatech Pharma plc
MTP
|
-1.76 M | - | -18.52 % | $ 27.3 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
1.92 B | $ 21.6 | 1.12 % | $ 1.01 B | ||
|
Checkpoint Therapeutics
CKPT
|
174 M | - | - | $ 169 M | ||
|
Институт стволовых клеток человека
ISKJ
|
14.1 M | - | - | - | ||
|
Adverum Biotechnologies
ADVM
|
125 M | - | - | $ 86.2 M | ||
|
Advaxis
ADXS
|
-3.02 M | - | -9.65 % | $ 45.9 M | ||
|
Clearside Biomedical
CLSD
|
122 M | - | - | $ 25.3 M | ||
|
Aeterna Zentaris
AEZS
|
10.3 M | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
3.93 M | - | -10.17 % | $ 12.2 K | ||
|
Aeglea BioTherapeutics
AGLE
|
-23.2 M | - | - | $ 1.01 B | ||
|
Akebia Therapeutics
AKBA
|
493 M | $ 1.54 | 4.77 % | $ 396 M | ||
|
Evogene Ltd.
EVGN
|
-4.88 M | $ 0.82 | -0.2 % | $ 27.9 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-9.16 M | - | - | $ 26.5 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
647 M | $ 3.11 | 6.51 % | $ 5.12 M | ||
|
Aquestive Therapeutics
AQST
|
540 M | $ 4.2 | 0.24 % | $ 449 M | ||
|
Forte Biosciences
FBRX
|
280 M | $ 34.19 | 11.75 % | $ 443 M | ||
|
Arcutis Biotherapeutics
ARQT
|
3.64 B | $ 25.23 | 4.6 % | $ 3.21 B | ||
|
Chimerix
CMRX
|
95.8 M | - | - | $ 756 M | ||
|
Concert Pharmaceuticals
CNCE
|
14.7 M | - | - | $ 401 M | ||
|
AIkido Pharma
AIKI
|
9.53 M | - | 1.93 % | $ 17.4 M | ||
|
Celldex Therapeutics
CLDX
|
2.07 B | $ 33.56 | 2.98 % | $ 2.23 B | ||
|
Autolus Therapeutics plc
AUTL
|
629 M | $ 1.49 | 1.02 % | $ 397 M | ||
|
Aptose Biosciences
APTO
|
36.2 M | - | -45.71 % | $ 1.2 M | ||
|
Cidara Therapeutics
CDTX
|
9.99 M | - | - | $ 1.41 B | ||
|
AVROBIO
AVRO
|
-35.4 M | - | 1083.1 % | $ 745 M | ||
|
CNS Pharmaceuticals
CNSP
|
-2.04 M | $ 2.46 | -2.19 % | $ 1.09 M | ||
|
Ayala Pharmaceuticals
AYLA
|
5.32 M | - | - | $ 7.46 M | ||
|
Galectin Therapeutics
GALT
|
306 M | $ 2.49 | 5.74 % | $ 159 M | ||
|
AstraZeneca PLC
AZN
|
59.6 B | - | - | $ 96.9 B | ||
|
Akero Therapeutics
AKRO
|
2.99 B | - | - | $ 3.67 B |